Cas no 29450-07-5 (2-(2-pyridyloxy)ethanamine)

2-(2-Pyridyloxy)ethanamine is a versatile amine derivative featuring a pyridyl ether linkage, making it a valuable intermediate in organic synthesis and pharmaceutical applications. Its bifunctional structure, combining a reactive amine group with a pyridyl moiety, enables its use in the preparation of ligands, catalysts, and biologically active compounds. The compound exhibits favorable solubility in polar organic solvents, facilitating its incorporation into various reaction systems. Its stability under standard conditions and compatibility with a range of chemical transformations enhance its utility in medicinal chemistry and material science. The pyridyl group also contributes to chelating properties, making it useful in coordination chemistry and metal-catalyzed processes.
2-(2-pyridyloxy)ethanamine structure
2-(2-pyridyloxy)ethanamine structure
Product Name:2-(2-pyridyloxy)ethanamine
CAS No:29450-07-5
MF:C7H10N2O
MW:138.167101383209
MDL:MFCD00090835
CID:282338
Update Time:2025-05-25

2-(2-pyridyloxy)ethanamine Chemical and Physical Properties

Names and Identifiers

    • 2-(2-pyridinyloxy)-Ethanamine
    • 2-(2-Pyridyloxy)ethanamine
    • 2-(Pyridin-2-yloxy)ethanamine
    • 2-(2-pyridinyloxy)Ethanamine
    • 2-pyridin-2-yloxyethanamine
    • Ethanamine,2-(2-pyridinyloxy)-
    • 2-(2-Aminoethoxy)pyridine
    • 2-(2-pyridinyloxy)ethaneamine
    • 2-(2-pyridyloxy)ethylamine
    • 2-(pyridin-2-yloxy)ethylamine
    • 2-(PYRIDIN-2-YLOXY)-ETHYLAMINE
    • 2-aminoethoxy-2-pyridine
    • AC1L3XFU
    • AC1Q57TI
    • NSC91884
    • Ethanamine, 2-(2-pyridinyloxy)-
    • 2-(pyridin-2-yloxy)ethan-1-amine
    • aminoethoxypyridine
    • NCIStruc2_000056
    • NCIStruc1_001752
    • 2-(2-pyridinyloxy) ethylamine
    • 2-(2-pyridyloxy)ethanamine
    • MDL: MFCD00090835
    • Inchi: 1S/C7H10N2O/c8-4-6-10-7-3-1-2-5-9-7/h1-3,5H,4,6,8H2
    • InChI Key: TUVONOFKFDJHBJ-UHFFFAOYSA-N
    • SMILES: O(C1C=CC=CN=1)CCN

Computed Properties

  • Exact Mass: 138.0794
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 10
  • Rotatable Bond Count: 3
  • Complexity: 87.7
  • XLogP3: 0.5
  • Topological Polar Surface Area: 48.1

Experimental Properties

  • Density: 1.089±0.06 g/cm3 (20 oC 760 Torr),
  • Melting Point: 216-222 oC
  • Boiling Point: 238 oC
  • Flash Point: 95.1±21.8 oC,
  • Solubility: Soluble (130 g/l) (25 o C),
  • PSA: 48.14
  • LogP: 1.11940

2-(2-pyridyloxy)ethanamine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A029184985-5g
2-(Pyridin-2-yloxy)ethanamine
29450-07-5 95%
5g
$396.00 2023-09-02
Alichem
A029184985-10g
2-(Pyridin-2-yloxy)ethanamine
29450-07-5 95%
10g
$756.00 2023-09-02
Fluorochem
208862-5g
2-(Pyridin-2-yloxy)ethanamine
29450-07-5 95%
5g
£329.00 2022-03-01
Fluorochem
208862-10g
2-(Pyridin-2-yloxy)ethanamine
29450-07-5 95%
10g
£591.00 2022-03-01
TRC
B525700-50mg
2-(Pyridin-2-yloxy)ethanamine
29450-07-5
50mg
$ 50.00 2022-06-07
TRC
B525700-100mg
2-(Pyridin-2-yloxy)ethanamine
29450-07-5
100mg
$ 65.00 2022-06-07
TRC
B525700-500mg
2-(Pyridin-2-yloxy)ethanamine
29450-07-5
500mg
$ 185.00 2022-06-07
Chemenu
CM175670-1g
2-(Pyridin-2-yloxy)ethanamine
29450-07-5 95%
1g
$128 2021-08-05
Chemenu
CM175670-5g
2-(Pyridin-2-yloxy)ethanamine
29450-07-5 95%
5g
$374 2021-08-05
Chemenu
CM175670-10g
2-(Pyridin-2-yloxy)ethanamine
29450-07-5 95%
10g
$673 2021-08-05

Additional information on 2-(2-pyridyloxy)ethanamine

Recent Advances in the Application of 2-(2-Pyridyloxy)ethanamine (CAS 29450-07-5) in Chemical Biology and Pharmaceutical Research

2-(2-Pyridyloxy)ethanamine (CAS 29450-07-5) has recently emerged as a versatile building block in medicinal chemistry and chemical biology. This bifunctional compound, featuring both pyridine and amine moieties, has shown significant potential in drug discovery and biochemical probe development. Recent studies highlight its utility as a key intermediate in the synthesis of novel therapeutic agents targeting various disease pathways.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's effectiveness as a scaffold for developing selective kinase inhibitors. Researchers utilized 2-(2-pyridyloxy)ethanamine to create a series of compounds showing nanomolar activity against specific tyrosine kinases involved in cancer progression. The structural flexibility of this compound allowed for optimal positioning of pharmacophores in the kinase binding pocket.

In neuropharmacology, recent work (Nature Chemical Biology, 2024) has explored the use of 29450-07-5 derivatives as modulators of neurotransmitter receptors. The compound's ability to cross the blood-brain barrier when appropriately modified has opened new avenues for central nervous system drug development. Particularly promising are its applications in designing novel antidepressants with faster onset of action.

The chemical properties of 2-(2-pyridyloxy)ethanamine have also been exploited in antibiotic development. A 2024 ACS Infectious Diseases publication reported its incorporation into next-generation quinolone antibiotics, showing enhanced activity against drug-resistant bacterial strains. The pyridine moiety appears to facilitate bacterial membrane penetration while the amine group enables targeted interactions with bacterial topoisomerases.

From a synthetic chemistry perspective, recent advances (Organic Letters, 2023) have improved the efficiency of 29450-07-5 production through catalytic amination methods. These developments have significantly reduced production costs while maintaining high purity standards required for pharmaceutical applications. The optimized synthetic routes now allow for kilogram-scale production with excellent yield and minimal byproducts.

Looking forward, the unique structural features of 2-(2-pyridyloxy)ethanamine continue to inspire innovative applications. Current research directions include its use in PROTAC (proteolysis targeting chimera) development and as a linker in antibody-drug conjugates. The compound's balanced hydrophilicity/lipophilicity profile makes it particularly valuable for these cutting-edge therapeutic modalities.

Recommended suppliers
NewCan Biotech Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
NewCan Biotech Limited
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.
Enjia Trading Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Enjia Trading Co., Ltd
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.